Developer docs
API playgroundTry for free, no card

Search company profiles

3BIGS

Full company profile

uuid0003nrx

Namestring
3BIGS
Websiteurl
3bigs.com
Company typeenum
Private
Founded yearint
2018
Short descriptiontext

3BIGS is a South Korean bioinformatics and AI company (founded 2017, Hwasong) using big data for genomics research, drug discovery, and data-driven healthcare solutions, serving pharmaceutical and healthcare sector clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHwasong, South Korea
HQ citystring
Hwasong
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
bioinformatics analytics, AI genomics research, drug discovery data, clinical big data, precision healthcare
Industry3 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Bioinformatics Software
Social media profiles2 records
Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

3BIGS provides AI- and big data-driven bioinformatics services and analytics for genomics research, drug discovery, and data-driven healthcare solutions. The company applies machine learning and large-scale genomic data processing to support life sciences research and pharmaceutical development pipelines for organizational clients.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1AI-driven Genomics Research Analytics
CategoryBioinformatics analytics
No data
Peers10 records
TypeEmerging player
Description

Oxford-based techbio combining automated lab experiments with AI/ML-driven analysis for drug discovery. Comparable emerging player at the intersection of data-driven biology and AI for pharma R&D.

TypeBroad incumbent
Description

US-listed computational chemistry and biology platform serving pharma R&D with molecular simulation plus a growing biotech pipeline. Comparable to 3BIGS's AI-for-drug-discovery angle but at vastly greater scale and breadth.

TypeDirect peer
Description

Korean AI-bio company using supercomputing and ML for drug discovery and biomarker development. Closely comparable to 3BIGS in geography, stage, and AI-driven genomics/drug-discovery focus.

TypeDirect peer
Description

Seoul-based genomics services and bioinformatics company. Closest geographic and functional peer to 3BIGS, providing sequencing, multi-omics analysis, and clinical genomics services to pharma and researchers in Korea and globally.

TypeDirect peer
Description

Korean AI-driven drug discovery company using proprietary AI workflows for target identification and lead optimization. Comparable to 3BIGS's drug-discovery ambitions and shares Korean ecosystem and customer base.

TypeDirect peer
Description

Swiss-based bioinformatics platform leveraging AI on multi-modal genomics and clinical data for hospital and research customers. Comparable to 3BIGS in combining bioinformatics, AI, and multi-omics analysis services at a more mature commercial stage.

TypeBroad incumbent
Description

Clinical-stage TechBio combining high-throughput biology with AI/ML to discover and develop medicines at scale. Comparable AI-meets-genomics thesis to 3BIGS but operates as a broad incumbent with pipeline assets.

TypeDirect peer
Description

US-based cloud genomics and biomedical data platform serving pharma, clinical, and research customers. Directly comparable to 3BIGS's big-data + bioinformatics positioning for genomics R&D.

TypeEmerging player
Description

US AI-driven drug discovery company combining ML with high-throughput biology for pharma partners. Comparable to 3BIGS in using AI on biological data for therapeutics discovery, but with substantially larger funding.

TypeRegional player
Description

India-headquartered genomics diagnostics and research services company with multi-omics analysis for clinicians and researchers. Comparable as a regional services + bioinformatics peer outside Korea.

Market position
Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

3BIGS

Bioinformatics Software3bigs.com

3BIGS is a South Korean bioinformatics and AI company (founded 2017, Hwasong) using big data for genomics research, drug discovery, and data-driven healthcare solutions, serving pharmaceutical and healthcare sector clients.

3BIGS firmographics

Firmographics
Name
3BIGS
Website
https://3bigs.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
3BIGS is a South Korean bioinformatics and AI company (founded 2017, Hwasong) using big data for genomics research, drug discovery, and data-driven healthcare solutions, serving pharmaceutical and healthcare sector clients.
Ownership category
akta.pro rank

3BIGS industry classification

Industry
Product category
Bioinformatics Software
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Bioinformatics analytics
  • AI genomics research
  • Drug discovery data
  • Clinical big data
  • Precision healthcare

Where 3BIGS is headquartered

Location

Headquarters

HQ city
Hwasong
HQ country
South Korea
HQ region
Asia

Markets served

3BIGS business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

3BIGS product offering

Product offering

Core offering

3BIGS provides AI- and big data-driven bioinformatics services and analytics for genomics research, drug discovery, and data-driven healthcare solutions. The company applies machine learning and large-scale genomic data processing to support life sciences research and pharmaceutical development pipelines for organizational clients.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI-driven Genomics Research Analytics

Companies that use 3BIGS

Customer profile

Ideal customer profiles2 records

3BIGS technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

3BIGS competitors and assessment

Company assessment

Emerging players

  • Arctoris: Oxford-based techbio combining automated lab experiments with AI/ML-driven analysis for drug discovery. Comparable emerging player at the intersection of data-driven biology and AI for pharma R&D.
  • Insitro: US AI-driven drug discovery company combining ML with high-throughput biology for pharma partners. Comparable to 3BIGS in using AI on biological data for therapeutics discovery, but with substantially larger funding.

Broad incumbents

  • Schrödinger: US-listed computational chemistry and biology platform serving pharma R&D with molecular simulation plus a growing biotech pipeline. Comparable to 3BIGS's AI-for-drug-discovery angle but at vastly greater scale and breadth.
  • Recursion Pharmaceuticals: Clinical-stage TechBio combining high-throughput biology with AI/ML to discover and develop medicines at scale. Comparable AI-meets-genomics thesis to 3BIGS but operates as a broad incumbent with pipeline assets.

Direct peers

  • Syntekabio: Korean AI-bio company using supercomputing and ML for drug discovery and biomarker development. Closely comparable to 3BIGS in geography, stage, and AI-driven genomics/drug-discovery focus.
  • Macrogen: Seoul-based genomics services and bioinformatics company. Closest geographic and functional peer to 3BIGS, providing sequencing, multi-omics analysis, and clinical genomics services to pharma and researchers in Korea and globally.
  • Standigm: Korean AI-driven drug discovery company using proprietary AI workflows for target identification and lead optimization. Comparable to 3BIGS's drug-discovery ambitions and shares Korean ecosystem and customer base.
  • SOPHiA GENETICS: Swiss-based bioinformatics platform leveraging AI on multi-modal genomics and clinical data for hospital and research customers. Comparable to 3BIGS in combining bioinformatics, AI, and multi-omics analysis services at a more mature commercial stage.
  • DNAnexus: US-based cloud genomics and biomedical data platform serving pharma, clinical, and research customers. Directly comparable to 3BIGS's big-data + bioinformatics positioning for genomics R&D.

Regional players

  • MedGenome: India-headquartered genomics diagnostics and research services company with multi-omics analysis for clinicians and researchers. Comparable as a regional services + bioinformatics peer outside Korea.

Market position

Customer concentration

3BIGS social profiles

Digital presence

3BIGS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

3BIGS leadership team

Management profile

Number of profiles

Profiles4 records

3BIGS funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

3BIGS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 3BIGS

What does 3BIGS do?

3BIGS provides AI- and big data-driven bioinformatics services and analytics for genomics research, drug discovery, and data-driven healthcare solutions. The company applies machine learning and large-scale genomic data processing to support life sciences research and pharmaceutical development pipelines for organizational clients.

Is 3BIGS a public or private company?

3BIGS is a private company. It is classified as venture growth investor backed and is currently operating.

When was 3BIGS founded?

3BIGS was founded in 2018. It employs 11 to 50 people.

Where is 3BIGS based?

3BIGS is headquartered in Hwasong, South Korea, in the Asia region.

Who are 3BIGS's main competitors?

Emerging players on record are Arctoris and Insitro. Broad incumbents are Schrödinger and Recursion Pharmaceuticals. Direct peers are Syntekabio, Macrogen, Standigm, SOPHiA GENETICS and DNAnexus. MedGenome is listed as a regional player.

Does 3BIGS have an API?

No public API is recorded for 3BIGS.

What industry is 3BIGS in?

3BIGS's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals